glp-1 medications approved for type 2 diabetes 2025 In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with Understanding GLP-1s and their dynamic

The analysis revealed significant changes in gut microbiome diversity, with specific microbial genera such as Akkermansia, Christensenella, and Oscillospiraceae associated with reductions in BMI

For those using Ozempic, maintaining stable glucose levels is critical

Move Your Body (Even a Little) You dont need intense workouts

Sarah Armstrong, pediatrician and medical weight management specialist with Duke Health, called the coverage game changing for all North Carolinians. Armstrong is also a member of the executive committee of the American Academy of Pediatrics Section on Obesity

Some signs of bowel obstruction are abdominal pain or cramping, nausea, vomiting, decreased appetite, constipation, and abdominal distention